pharma

Latest stories

  • in Health care

    Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma, Sandoz

    by

    Thousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. and Zydus Pharmaceuticals (USA), Inc. The decision affirms the permanent injunction entered by the district court prohibiting Sandoz and […] More

  • in Health care

    CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda

    by

    New Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited. The proposed combination relates to acquisition by Berhyanda Limited (Acquirer) for up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited (Target), by way of a […] More

  • in Health care

    Piramal Pharma gets USFDA EIR for Sellersville facility

    by

    Mumbai: Piramal Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded the inspection of the company’s manufacturing facility located at Sellersville, USA and has issued an Establishment Inspection Report (EIR) for the said facility. EIR is the final inspection report of an FDA inspection. The inspection was held between December 19, […] More

  • in Health care

    Mankind Pharma sets IPO price band of Rs 1,026 to Rs 1,080 per share

    by

    Bengaluru: Indian pharmaceutical company Mankind Pharma Ltd has set a price band of 1,026 rupees to 1,080 rupees per share for its initial public offering (IPO), according to a newspaper advertisement, valuing the company at 432.64 billion rupees ($5.27 billion) at the upper end of the band. The IPO for the company, which owns the […] More

  • in Health care

    Glenmark Pharma weighs selling stake in Glenmark Lifesciences

    Glenmark Pharma weighs selling stake in Glenmark Lifesciences

    by

    Bengaluru: India’s Glenmark Pharmaceuticals Ltd is considering selling a majority of the 82% stake it holds in Glenmark Life Sciences Ltd as it looks to lower its debt load, the Mint business daily reported on Tuesday. Glenmark Pharma has hired Kotak Mahindra Capital Co Ltd to oversee the sale of its stake in Glenmark Life and […] More

  • in Health care

    Riad Mishlawi to become CEO of Hikma Pharma

    Riad Mishlawi to become CEO of Hikma Pharma

    by

    New Delhi: Generic drugmaker Hikma Pharmaceuticals Plc said on Wednesday that Riad Mishlawi, president of the group’s injectables business, will become its chief executive officer, effective Sept. 1. The London-based company said once Mishlawi takes up the role, Said Darwazah will step down as acting CEO and return to his role as executive chairman. Mishlawi, […] More

  • in Health care

    SC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir without valid license

    SC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir without valid license

    by

    New Delhi: The Supreme Court on Monday dismissed a plea alleging use of drugs Remdesivir and Favipiravir, without approval, for treatment of Covid-19 and also seeking CBI probe against ten Indian pharmaceutical firms for selling these medicines allegedly in the absence of valid licenses. A bench, headed by Chief Justice of India D.Y. Chandrachud and […] More

  • in Health care

    Cipla joins hands with Novartis Pharma AG to market diabetes drug Galvus in India

    Cipla joins hands with Novartis Pharma AG to market diabetes drug Galvus in India

    by

    Mumbai: Pharma major, Cipla Limited, has announced that it has signed a perpetual license agreement with Novartis Pharma AG (Switzerland) to manufacture and market Galvus and Galvus combination brands, used in the treatment of type 2 diabetes from 1st January 2026. The agreement is subject to satisfaction of certain conditions precedent, Cipla informed. “During the […] More

  • in Health care

    Torrent Pharma unveils generic version of Keveyis tablets in US

    Torrent Pharma unveils generic version of Keveyis tablets in US

    by

    Basking Ridge: Torrent Pharma has begun shipping the generic version of Xeris’s Keveyis (dichlorphenamide), 50mg tablets, following final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application. Torrent is distributing the product through select specialty pharmacies beginning this month. Dichlorphenamide Tablets are indicated for the treatment of primary hyperkalemic periodic […] More

Load More
Congratulations. You've reached the end of the internet.